ARCT Arcturus Therapeutics Ltd.

Arcturus Therapeutics Ltd is a biotechnology company developing novel RNA medicines. The company develops novel RNA medicines in therapeutic areas including infectious disease, cystic fibrosis, nonalcoholic steatohepatitis (NASH) and rare liver diseases.

$16.14  +0.40 (2.51%)
As of 07/01/2022 15:59:50 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  05/22/2013
Outstanding shares:  26,418,965
Average volume:  790,729
Market cap:   $406,852,061
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BKC9SX3
Valuation   (See tab for details)
PE ratio:   -2.09
PB ratio:   2.25
PS ratio:   26.29
Return on equity:   -107.44%
Net income %:   -1,282.61%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy